Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11
generalAcute myeloid leukemia characterized by the presence of abnormal bone marrow eosinophils and the characteristic cytogenetic abnormality t(16;16)(p13.1;q22) which results in the expression of the fusion protein CBFB-MYH11.
64
Centers
15
Active Trials
$16.9B
Cancer Funding
Specific Cancer Types(1)
Top Centers for Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11(64)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →